Literature DB >> 2972548

The influence of antihistamines on human performance.

A W Gaillard1, A Gruisen, R de Jong.   

Abstract

We have studied the effects of three antihistamines on task performance in two separate experiments. Healthy subjects were tested at weekly intervals in a double-blind, Latin square design. In Experiment I the subjects were treated orally with loratadine 10 mg, clemastine 1 mg, terfenadine 60 mg, or placebo. In Experiment II 5 mg diazepam was given orally with each of the four treatments used in Experiment I. In both experiments subjects' performance was evaluated in reaction time and tracking tasks after treatment. In both experiments, the tracking task initially was performed alone and then simultaneously with a continuous memory task; the subject also graded their mental status on visual analogue rating scales. In both experiments task performance was not generally impaired after treatment with loratadine or terfenadine. The concomitant administration of diazepam in Experiment II appeared not to affect subjects' performance. However, clemastine caused a decay in subjects' performance in both Experiments I and II, but only on the tracking task. At the conclusion of both experiments, sleepiness was reported by more subjects when treated with clemastine than when treated with loratadine, terfenadine, or placebo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972548     DOI: 10.1007/bf00558261

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Performance studies with antihistamines.

Authors:  C H Clarke; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

2.  EP components, visual processing stages, and the effect of a barbiturate.

Authors:  H W Frowein; A W Gaillard; C A Varey
Journal:  Biol Psychol       Date:  1981-12       Impact factor: 3.251

3.  An additive factor analysis of the effects of sleep loss on reaction processes.

Authors:  A F Sanders; J L Wijnen; A E van Arkel
Journal:  Acta Psychol (Amst)       Date:  1982-08

Review 4.  Terfenadine, a nonsedating antihistamine.

Authors:  C A Carter; N J Wojciechowski; J M Hayes; V A Skoutakis; L A Rickman
Journal:  Drug Intell Clin Pharm       Date:  1985-11

5.  Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

6.  Antihistamines and visual function: studies on dynamic acuity and the pupillary response to light.

Authors:  A N Nicholson; P A Smith; M B Spencer
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

7.  Benzodiazepines impair smooth pursuit eye movements.

Authors:  P R Bittencourt; P Wade; A T Smith; A Richens
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

Review 8.  Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  E M Sorkin; R C Heel
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

  8 in total
  14 in total

1.  Comparative pharmacodynamics of Ro 41-3696, a new hypnotic, and zolpidem after night-time administration to healthy subjects.

Authors:  J Dingemanse; M Bury; J Bock; P Joubert
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

Review 2.  Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

Review 3.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Effects of terfenadine on psychomotor performance. An overview.

Authors:  D W Aaronson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

Review 5.  Loratadine. A review of recent findings in pharmacology, pharmacokinetics, efficacy, and safety, with a look at its use in combination with pseudoephedrine.

Authors:  I J Roman; M R Danzig
Journal:  Clin Rev Allergy       Date:  1993

6.  Histamine H1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance.

Authors:  P van Ruitenbeek; A Vermeeren; F T Y Smulders; A Sambeth; W J Riedel
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

Review 7.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

8.  Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.

Authors:  Patrick W Sullivan; Sheryl L Follin; Michael B Nichol
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 9.  Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies.

Authors:  J Jolles; F R Verhey; W J Riedel; P J Houx
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

Review 10.  Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy.

Authors:  D McTavish; K L Goa; M Ferrill
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.